Drug Profile
Research programme: ghrelin receptor inverse agonists - Helsinn
Latest Information Update: 28 Nov 2019
Price :
$50
*
At a glance
- Originator Helsinn
- Class
- Mechanism of Action Ghrelin inverse agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Obesity
Most Recent Events
- 28 Nov 2019 No recent reports of development identified for research development in Obesity in Europe